EY estimates the extinct-species educational/consumer market at $1.7 trillion annually
Predictor: EY (Ernst & Young) · ep#245 "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)" · source
Prediction text
EY estimates the extinct-species educational/consumer market at $1.7 trillion annually | the world spends about 12 and a half uh percent uh 12 and a half% of global consumers buy something that's extinct every year. Like and so turns out to be like $1.7 trillion.
Verbatim quote
the world spends about 12 and a half uh percent uh 12 and a half% of global consumers buy something that's extinct every year. Like and so turns out to be like $1.7 trillion.
Predictor: EY (Ernst & Young)
Evidence about this node from EY (Ernst & Young) is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).
Reference class
This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.
Probability over time
Milestone chain
- 2026-05-01 → 2026-12-31pendingColossal Biosciences valuation maintained at >=$10B with no public revenue (TAM remains forecast-stage)How: Colossal valuation per latest Series funding round or PitchBook profile remains >=$10B AND Colossal continues to disclose zero or near-zero commercial revenue per public filings/coverageSource: deep_research_enrichedconf 85%
- 2026-06-01 → 2027-12-31pendingEY or Big-4 firm publishes updated extinct-species/biodiversity TAM forecast referencing $1.7T figure or successorHow: EY, PwC, Deloitte, or KPMG publishes biodiversity/de-extinction-related TAM report citing $1T+ consumer spending on extinct/biodiversity-themed productsSource: deep_research_enrichedconf 45%
- 2027-01-01 → 2029-12-31pendingFirst Colossal commercial product (mammoth-derived therapeutic, dire wolf merch, conservation IP licensing) generates measurable revenueHow: Colossal annual report or press release confirms >$10M revenue from any de-extinction-derived commercial product, validating non-zero TAM realizationSource: deep_research_enrichedconf 50%
No downstream cascades — this prediction is a leaf in the dependency graph.
What if this resolves?
Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"
Evidence chain
Network propagation neighbors
Top incoming (parents)
Edges that influence THIS node's belief
| Kind | Node | Their prob | P(c|s=T) | P(c|s=F) | Δ implied |
|---|---|---|---|---|---|
| killer | TK05 Rate Regime Persistence (10y > 5% through 2028) | 30.0% | 0.050 | 0.500 | -0.060 |
| killer | TK12 Crypto Regulatory Kill Shot (Stablecoin Ban / BTC ETF Revers | 8.0% | 0.050 | 0.500 | +0.039 |
| killer | TK04 Macro Recession 2026-27 (Structural Deleveraging) | 25.0% | 0.050 | 0.500 | -0.038 |
| killer | TK10 $100T Sovereign Debt Crisis | 12.0% | 0.050 | 0.500 | +0.021 |
| killer | TK14 Superbubble Pop (S&P 500 -40%, Moonshot Capital Evaporates) | 20.0% | 0.050 | 0.500 | -0.015 |
Top outgoing (children)
Predictions THIS node influences
No outgoing edges.
Ticker exposure
Beneficiaries (23)
Adverse (5)
Prerequisites (5)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| killer | TK05 | Rate Regime Persistence (10y > 5% through 2028) | — | — |
| killer | TK04 | Macro Recession 2026-27 (Structural Deleveraging) | — | — |
| killer | TK14 | Superbubble Pop (S&P 500 -40%, Moonshot Capital Evaporates) | — | — |
| killer | TK10 | $100T Sovereign Debt Crisis | — | — |
| killer | TK12 | Crypto Regulatory Kill Shot (Stablecoin Ban / BTC ETF Reversal) | — | — |
Dependents (0)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| No dependents | ||||
Linked documents (3)
| Sim | Source | Title | Market prob | Polarity | Reviewed | Published |
|---|---|---|---|---|---|---|
| 0.656 | manifold | How many 10s of thousands of species be on OneZoom at the end of this year? | 66% | mentions | pending | 2026-06-02 |
| 0.654 | manifold | How many unique viewers will this market end with? | — | mentions | pending | 2026-05-30 |
| 0.618 | manifold | Will the wild population of North Atlantic Right Whale (Eubalaena glacialis) become Extinct by 2100? | 82% | mentions | pending | 2026-04-24 |
Raw metadata
{
"nia": false,
"qty": "$1.7 trillion annually; 12.5% of global consumers",
"url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
"mode": "CITED_PREDICTION",
"role": "Cited-Firm",
"context": "EY did an estimate of the size of the market for you?... 12 and a half% of global consumers buy something that's extinct every year... turns out to be like $1.7 trillion.",
"cited_by": "Ben Lamm",
"verbatim": "the world spends about 12 and a half uh percent uh 12 and a half% of global consumers buy something that's extinct every year. Like and so turns out to be like $1.7 trillion.",
"conv_cues": "they said; turns out to be",
"direction": "NUMERIC_TARGET",
"timeframe": "Annual / current",
"conv_level": "MEDIUM",
"milestones": [
{
"kind": "llm_pre_event",
"label": "Colossal Biosciences valuation maintained at >=$10B with no public revenue (TAM remains forecast-stage)",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -3,
"source_id": null,
"confidence": 0.85,
"source_url": "https://news.crunchbase.com/venture/de-extinction-startup-colossal-decacorn-twg-walter-tull/",
"expected_date": "2026-08-31",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2026-12-31",
"from": "2026-05-01"
},
"measurement_criterion": "Colossal valuation per latest Series funding round or PitchBook profile remains >=$10B AND Colossal continues to disclose zero or near-zero commercial revenue per public filings/coverage"
},
{
"kind": "llm_pre_event",
"label": "EY or Big-4 firm publishes updated extinct-species/biodiversity TAM forecast referencing $1.7T figure or successor",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -2,
"source_id": null,
"confidence": 0.45,
"source_url": "https://www.ey.com/content/dam/ey-unified-site/ey-com/en-gl/insights/financial-services/documents/ey-waking-up-to-nature-the-biodiversity-imperative-in-financial-services.pdf",
"expected_date": "2027-03-17",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2027-12-31",
"from": "2026-06-01"
},
"measurement_criterion": "EY, PwC, Deloitte, or KPMG publishes biodiversity/de-extinction-related TAM report citing $1T+ consumer spending on extinct/biodiversity-themed products"
},
{
"kind": "llm_post_event",
"label": "First Colossal commercial product (mammoth-derived therapeutic, dire wolf merch, conservation IP licensing) generates measurable revenue",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -1,
"source_id": null,
"confidence": 0.5,
"source_url": "https://research.contrary.com/company/colossal-biosciences",
"expected_date": "2028-07-01",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2029-12-31",
"from": "2027-01-01"
},
"measurement_criterion": "Colossal annual report or press release confirms >$10M revenue from any de-extinction-derived commercial product, validating non-zero TAM realization"
}
],
"repeat_eps": 1,
"untimeable": true,
"affiliation": "Ernst & Young",
"attribution": "THIRD_PARTY_CITATION",
"episode_num": 245,
"granularity": "VAGUE",
"episode_date": "2026-04-07",
"parse_method": "UNMAPPABLE",
"domain_bucket": "Labor",
"episode_title": "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)",
"fault_line_id": "F001, F002, F005",
"flag_repeated": false,
"in_5yr_window": false,
"appears_in_eps": "245",
"consensus_size": 9,
"is_macro_claim": true,
"macro_span_end": "2031-03",
"total_mentions": 1,
"priority_weight": 2,
"ps_cluster_tags": [
"C10",
"C5",
"C6",
"C8"
],
"active_end_
... (truncated)